Table 1 Clinical data for all patients included in this study

From: Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment

 

Multi-layered spatial’ omics (n = 8)

Bulk transcriptomics & metabolomics (n = 37)

 

Aggressive (n = 5)

Non-aggressive (n = 3)

Aggressive (n = 27)

Non-aggressive (n = 10)

ISUP grade

ISUP2, n = 1

ISUP2, n = 2

ISUP2, n = 7

ISUP2, n = 8

ISUP3, n = 1

ISUP3, n = 1

ISUP3, n = 10

ISUP3, n = 2

ISUP4, n = 1

 

ISUP4, n = 4

 

ISUP5, n = 2

 

ISUP5, n = 6

 

Mean age and range at surgery

59 (53–73)

60.7 (56–63)

62.4 (51–73)

59.8 (55–66)

Mean preoperative PSA

23.7

14.0

18.7

10.8

Clinical T-stagea

T2c, n = 1

T2c, n = 2a

T2c, n = 9

T2c, n = 9

T3a, n = 2

 

T3a, n = 6

 

T3b, n = 2

 

T3b, n = 12

 
  1. The table is divided by patients of which tissue samples were used for multi-layered spatial’ omics and bulk transcriptomics and metabolomics.
  2. aFor one patient T-stage information was not available.
Back to article page